Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-08

FDA Approved: ATAZANAVIR — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Camber Pharmaceuticals' generic atazanavir. Atazanavir is used in the treatment of HIV infection in combination with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATAZANAVIR (atazanavir)

Snippet

SUPPL AP for ATAZANAVIR (ATAZANAVIR)